Skip to main content
OpenTrials

Clinical trial condition

Sphingolipidoses

Explore clinical trials studying Sphingolipidoses. Study availability and eligibility vary by location and protocol.

389 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Sphingolipidoses trial results

Completed

A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease

NCT00074984

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of San Francisco San Francisco, California, United States
  • University of Connecticut Health Partners Farmington, Connecticut, United States
View all 26 locations
View Trial Details
Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

NCT00074971

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California San Fransisco San Francisco, California, United States
  • Northwest Oncology & Hematology Associates Coral Springs, Florida, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

NCT00446862

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emory University Atlanta, Georgia, United States
  • Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details

Related conditions